ICD-10-CM Billable Code

C91.4

Hairy cell leukemia

Clinical Classification Guidelines

Inclusion Terms

  • Leukemic reticuloendotheliosis

Medical Intelligence & Overview

Hairy Cell Leukemia is a rare form of chronic leukemia characterized by the uncontrolled growth of abnormal B lymphocytes, a type of white blood cell. Named for the hair-like projections on the surface of the cancer cells, this disease primarily affects middle-aged and older adults. It is classified under leukemic reticuloendotheliosis, a group of slow-growing blood cancers that originate in the lymphatic system. While it is a rare condition, understanding its features can help in early recognition and management.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting B lymphocytes Potential environmental exposures, though specific risk factors are not well established No clear inheritance pattern identified Exposure to certain chemicals or radiation may contribute, but evidence is limited

Key Symptoms: Persistent fatigue or tiredness Unexplained weight loss Swollen lymph nodes, especially in the neck, armpits, or groin Frequent infections or recurrent illness Abdominal discomfort or fullness due to enlarged spleen Easy bruising or bleeding tendencies Fever or night sweats without an apparent infection Skin infections or unusually frequent infections

Diagnostic & Treatment

Diagnosis Path: The diagnosis of Hairy Cell Leukemia involves a combination of blood tests, bone marrow examination, and imaging studies. Blood counts often reveal anemia, low platelet, and white cell counts. A peripheral blood smear can show the characteristic hairy-looking lymphocytes. Bone marrow aspiration and biopsy provide definitive evidence, revealing abnormal B lymphocytes with hair-like projections. Flow cytometry and immunophenotyping are used to confirm the diagnosis by identifying specific cell surface markers. Additional imaging such as ultrasound may be employed to assess spleen size.

Treatment Protocols: Treatment strategies aim to control symptoms and manage disease progression. Common options include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C91.4 a billable ICD-10 code?
Yes, C91.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C91.4?
Clinical documentation must specify the nature of Hairy cell leukemia and any associated comorbidities for accurate reporting.

Cite this Clinical Reference